loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2020_274___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Cohance Lifesciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    INTERMEDIATES

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 COHANCE LIFESCIENCES LIMITED Mumbai IN (1)

    filter

    01 Rivaroxaban (1)

    filter

    01 India (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    COHANCE LIFESCIENCES LIMITED Mumbai...

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
    Contact Supplier Contact Supplier
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Rivaroxaban

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF CN
    CEP 2020-274 - Rev 02
    Valid
    Chemical
    2024-06-28
    2932
    Cohance

    CPhI Worldwide, Milan

    Booth #4B1

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for CEP 2020-274 - Rev 02 of Cohance Lifesciences Limited Mumbai In

    Looking for Certificates of Suitability (CEPs) for CEP 2020-274 - Rev 02 of Cohance Lifesciences Limited Mumbai In 1

    20

    Cohance Lifesciences Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    They are recognized for Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    One of their significant offerings is Rivaroxaban, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2020-274 - Rev 02

    This Chemical Type CEP, issued on June 28, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2932 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY